In This Article:
-
Organic Revenue Growth: 2.6% in Q3 2024.
-
Adjusted EBITDA Growth: 3.5% in Q3 2024.
-
Adjusted Earnings Per Share Growth: 3.6% in Q3 2024.
-
Plastic and Devices Organic Revenue Growth: 8% in Q3 2024.
-
Plastic and Devices Adjusted EBITDA Growth: 11% in Q3 2024.
-
Primary Packaging Glass Organic Revenue Decline: 3% in Q3 2024.
-
Primary Packaging Glass Adjusted EBITDA Decline: 9.4% in Q3 2024.
-
Revenues: Increased from EUR488 million to EUR499 million in Q3 2024.
-
Adjusted EBITDA Margin: Increased by 20 basis points to 20.9% in Q3 2024.
-
Adjusted EPS: Increased from EUR1.07 to EUR1.16 in Q3 2024.
-
Net Financial Debt: EUR1.1 billion as of Q3 2024.
-
Adjusted EBITDA Leverage: Increased from 2.3x to 2.6x.
-
Free Cash Flow Expectation for Q4 2024: Between plus EUR50 million to EUR100 million.
-
2024 Organic Revenue Growth Guidance: 3% to 4%.
-
2024 Adjusted EBITDA Guidance: EUR415 million to EUR430 million.
-
2024 Adjusted EPS Growth Guidance: 2% to 8%.
-
2025 Organic Revenue Growth Guidance: 7% to 10%.
-
2025 EBITDA Margin Guidance: Around 22%.
Release Date: September 30, 2024
For the complete transcript of the earnings call, please refer to the full earnings call transcript.
Positive Points
-
Gerresheimer AG (GRRMY) achieved an organic revenue growth of 2.6% in Q3 2024.
-
The company's adjusted EBITDA grew by 3.5%, indicating profitable growth.
-
Plastic and devices segment showed strong performance with an 8% organic revenue growth and 11% adjusted EBITDA growth.
-
The company is experiencing strong growth in product solutions for large molecule biologics, such as GLP-1.
-
Gerresheimer AG (GRRMY) expects a stronger Q4 2024 as new production lines ramp up and destocking effects fade.
Negative Points
-
Gerresheimer AG (GRRMY) had to revise its growth guidance for 2024 and 2025 due to slower-than-expected market recovery.
-
Primary packaging glass segment experienced a 3% organic revenue decline due to ongoing destocking.
-
Hurricane Helene caused significant flooding at the Morganton vial plant, halting production for several weeks.
-
The company anticipates a softer growth rebound in the vial market, impacting 2025 results.
-
Gerresheimer AG (GRRMY) faces challenges with slower demand in molded glass products for the food and beverage industry.
Q & A Highlights
Q: What drove the decision to revise the 2025 sales growth outlook, and is it primarily due to the vial market? A: The revision is mainly driven by the vial market, where the rebound effect is slower and softer than expected. Other factors include the impact of Hurricane Helene on the Morganton plant and softer demand in molded glass products for the food and beverage industry. (Dietmar Siemssen, CEO)